These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32877010)

  • 41. Seasonal variability in body mass index change among children enrolled in the Pediatric Obesity Weight Evaluation Registry: A step in the right direction.
    Lane TS; Sonderegger DL; Binns HJ; Kirk S; Christison AL; Novick M; Tucker J; King E; Wallace S; Brazendale K; Kharofa RY; Walka S; Heer H';
    Pediatr Obes; 2023 May; 18(5):e13012. PubMed ID: 36811325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.
    Kannan S; Bahl A; Khosla PP
    Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists.
    Kearns MA; Hawley KM
    J Psychiatr Pract; 2014 Nov; 20(6):438-47. PubMed ID: 25406048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.
    Efron D; Hiscock H; Sewell JR; Cranswick NE; Vance AL; Tyl Y; Luk ES
    Pediatrics; 2003 Feb; 111(2):372-5. PubMed ID: 12563066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice.
    Gadde KM; Pritham Raj Y
    Curr Diab Rep; 2017 May; 17(5):34. PubMed ID: 28378293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prescribing preferences in rapid tranquillisation: a survey in Belgian psychiatrists and emergency physicians.
    Bervoets C; Roelant E; De Fruyt J; Demunter H; Dekeyser B; Vandenbussche L; Titeca K; Pieters G; Sabbe B; Morrens M
    BMC Res Notes; 2015 Jun; 8():218. PubMed ID: 26043843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacotherapy for Obesity.
    Saunders KH; Shukla AP; Igel LI; Kumar RB; Aronne LJ
    Endocrinol Metab Clin North Am; 2016 Sep; 45(3):521-38. PubMed ID: 27519128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient Retention in Pediatric Weight Management Programs in the United States: Analyses of Data from the Pediatrics Obesity Weight Evaluation Registry.
    Skinner AC; Xu H; Christison A; Neshteruk C; Cuda S; Santos M; Yee JK; Thomas L; King E; Kirk S
    Child Obes; 2022 Jan; 18(1):31-40. PubMed ID: 34415779
    [No Abstract]   [Full Text] [Related]  

  • 49. Changes in psychosocial health during a 7-week paediatric weight management program.
    Tucker JM; Howard K; DeLaFuente K; Cadieux A; Yee KE
    Clin Obes; 2017 Dec; 7(6):393-401. PubMed ID: 28871630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adolescent experiences of anti-obesity drugs.
    White B; Jamieson L; Clifford S; Shield JP; Christie D; Smith F; Wong IC; Viner RM
    Clin Obes; 2015 Jun; 5(3):116-26. PubMed ID: 25974187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Utilization and perspectives of weight loss medications in pediatric metabolic dysfunction-associated steatotic liver disease.
    Kehar M; Ibrahim SH; Ramirez CM; Amin SA; Diamond T; Mohammad S
    J Pediatr Gastroenterol Nutr; 2024 Sep; 79(3):661-666. PubMed ID: 38698664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in Japan.
    Tsujii N; Saito T; Izumoto Y; Usami M; Okada T; Negoro H; Iida J
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):642-5. PubMed ID: 26103533
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topiramate for Weight Management in Children With Severe Obesity.
    Berman C; Naguib M; Hegedus E; Vidmar AP
    Child Obes; 2023 Jun; 19(4):219-225. PubMed ID: 35767803
    [No Abstract]   [Full Text] [Related]  

  • 54. Combination phentermine and topiramate for weight maintenance: the first Australian experience.
    Neoh SL; Sumithran P; Haywood CJ; Houlihan CA; Lee FT; Proietto J
    Med J Aust; 2014 Aug; 201(4):224-6. PubMed ID: 25164851
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On-label and off-label prescribing patterns of erythropoiesis-stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes.
    Seetasith A; Holdford D; Shah A; Patterson J
    Res Social Adm Pharm; 2017; 13(4):778-788. PubMed ID: 27595426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National trends in the management of cardiovascular disease risk factors in children: second NHLBI survey of primary care physicians.
    Kimm SY; Payne GH; Stylianou MP; Waclawiw MA; Lichtenstein C
    Pediatrics; 1998 Nov; 102(5):E50. PubMed ID: 9794980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prescribing for weight loss in primary care: evidence from a population based study.
    Patterson L; Patterson C; Kee F; Hughes C; Donnelly M; O'Reilly D
    J Epidemiol Community Health; 2013 Jun; 67(6):530-2. PubMed ID: 23364026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. National opioid prescribing trends in emergency departments by provider type: 2005-2015.
    Yang BK; Storr CL; Trinkoff AM; Sohn M; Idzik SK; McKinnon M
    Am J Emerg Med; 2019 Aug; 37(8):1439-1445. PubMed ID: 30377010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacotherapy for Weight Management in the VHA.
    Semla TP; Ruser C; Good CB; Yanovski SZ; Ames D; Copeland LA; Billington C; Ferguson UI; Aronne LJ; Wadden TA; Garvey WT; Apovian CM; Atkins D
    J Gen Intern Med; 2017 Apr; 32(Suppl 1):70-73. PubMed ID: 28271432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on obesity pharmacotherapy.
    Bray GA; Ryan DH
    Ann N Y Acad Sci; 2014 Apr; 1311():1-13. PubMed ID: 24641701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.